EPS

Rithm Capital declared its 52nd straight dividend. Is its high yield and analyst praise enough to overcome recent stock woes and market skepticism?

The shipping firm is buying back up to 1 million shares at $3.00 each, a massive premium over its current market price, signaling deep undervaluation.

Capstone Holding Corp. merges Midwest operations, targeting positive EBITDA by 2026 amid major project wins and a disciplined cost-cutting campaign.

Investors eye Cardinal Health's April 30 report for signs its aggressive diversification and specialty pharma push can sustain its powerful earnings momentum.

Following a record year, Knight Therapeutics is doubling its share repurchase plan. We analyze the strategy, financials, and what it means for investors.

As Capital One preps its Q1 2026 results, all eyes are on whether its pioneering tech strategy can navigate economic headwinds and justify its big bets.

Micro-Tech Endoscopy brings key GI products in-house as CONMED exits the market. The move ensures clinician access and strengthens Micro-Tech’s global position.

As HireQuest preps its 2025 results, investors watch if its franchise model can navigate a cooling, tech-driven labor market and offer clues for 2026.

Chinese lifestyle group Atour surpasses growth targets with a 35% revenue jump, fueled by hotel expansion and a booming retail business.

As executives head to a key summit, all eyes are on OPENLANE's plan to navigate a used car market ripe with digital opportunity and economic risk.

Cybersecurity firm Telos smashes Q4 estimates, driving its stock up over 21% with a strong forecast amid booming demand for identity and cloud security.

Amid economic uncertainty, M&T Bank's CEO reveals a record $2.88B profit, crediting a focus on local markets and long-term value over risky growth.

Amid a strategic overhaul, Koppers Holdings aims to woo investors with a story of improved profitability and its essential role in global infrastructure.

OCI Global nets $172.6M from a major Methanex share sale, a strategic move as both chemical giants face financial pressure and a volatile methanol market.

The healthcare REIT's significant dividend increase is backed by a record year of investment, a strong balance sheet, and strategic expansion into new markets.

The engineering giant renews its massive share buyback plan, signaling deep confidence in its stock amid a nuclear boom and a unique pact with La Caisse.

The nation's largest landscaper affirms its financial health by paying an $8.8M cash dividend, avoiding share dilution and signaling confidence to investors.

Amid a complex healthcare market, The Ensign Group will outline its aggressive growth and operational playbook for investors at the upcoming Oppenheimer conference.

Strathcona Resources to repurchase up to 5% of its shares, calling them undervalued. The move signals strong confidence and boosts shareholder value.

BRC Group Holdings announced a major debt reduction, but a history of late filings, shareholder dilution, and high-risk bets cast a shadow on its recovery.